NCT02583256 - Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989) | Biotech Hunter

Enrollment

1,601

Participants

Timeline

Start Date

January 29, 2016

Primary Completion Date

November 15, 2016

Study Completion Date

May 9, 2017

Conditions

Influenza

Interventions

BIOLOGICAL

Adjuvanted QIV (aQIV)

Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)

BIOLOGICAL

Non-adjuvanted QIV

Non-adjuvanted Quadrivalent Influenza Vaccine (QIV)

Trial Locations (17)

1781

Investigational Site- 303, Laguna

Investigational Site- 304, Muntinlupa

Investigational Site- 305, Muntinlupa

4114

Investigational Site- 306, Cavite

10330

Investigational Site- 323, Bangkok

10400

Investigational Site- 320, Bangkok

Investigational Site- 327, Bangkok

12120

Investigational Site- 325, Pathum Thani

20520

Investigational Site- 010, Turku

28100

Investigational Site- 007, Pori

33100

Investigational Site- 009, Tampere

67100

Investigational Site- 005, Kokkola

90220

Investigational Site- 006, Oulu

02230

Investigational Site- 001, Espoo

00100

Investigational Site- 002, Helsinki

Investigational Site- 003, Helsinki

04400

Investigational Site- 004, Järvenpää

All Listed Sponsors

lead

Seqirus

INDUSTRY